Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Shares of Bath & Body Works, Inc. (NYSE:BBWI - Get Rating) have been assigned a consensus rating of "Moderate Buy" from the twenty-three brokerages that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, ten have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $53.05.

Several brokerages have recently weighed in on BBWI. Cowen lowered their target price on Bath & Body Works from $82.00 to $60.00 in a report on Friday, May 20th. Evercore ISI boosted their target price on Bath & Body Works to $40.00 in a report on Monday, August 22nd. Raymond James boosted their target price on Bath & Body Works from $43.00 to $48.00 and gave the stock a "strong-buy" rating in a report on Friday, August 19th. Citigroup boosted their target price on Bath & Body Works to $48.00 in a report on Monday, August 22nd. Finally, Telsey Advisory Group upped their price objective on Bath & Body Works from $40.00 to $52.00 and gave the company an "outperform" rating in a report on Thursday, August 18th.Bath & Body Works Trading Down 2.4 %

BBWI stock opened at $37.38 on Friday. Bath & Body Works has a 12-month low of $25.75 and a 12-month high of $82.00. The stock has a market cap of $8.54 billion, a price-to-earnings ratio of 9.92, a PEG ratio of 0.91 and a beta of 1.77. The business's 50-day moving average is $35.83 and its 200 day moving average is $41.18.

Bath & Body Works (NYSE:BBWI - Get Rating) last posted its quarterly earnings data on Wednesday, August 17th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.11. The company had revenue of $1.62 billion for the quarter, compared to analysts' expectations of $1.61 billion. Bath & Body Works had a negative return on equity of 52.60% and a net margin of 12.31%. Bath & Body Works's revenue was down 5.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.34 EPS. As a group, equities analysts forecast that Bath & Body Works will post 2.88 EPS for the current fiscal year. Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 2nd. Stockholders of record on Friday, August 19th were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.14%. The ex-dividend date was Thursday, August 18th. Bath & Body Works's dividend payout ratio is currently 21.22%. Institutional Trading of Bath & Body Works

Large investors have recently modified their holdings of the stock. Prudential PLC increased its position in shares of Bath & Body Works by 8.5% during the first quarter. Prudential PLC now owns 47,840 shares of the company's stock worth $2,287,000 after acquiring an additional 3,728 shares during the period. Teacher Retirement System of Texas increased its position in shares of Bath & Body Works by 53.1% during the first quarter. Teacher Retirement System of Texas now owns 148,959 shares of the company's stock worth $7,120,000 after acquiring an additional 51,685 shares during the period. AIA Group Ltd grew its stake in shares of Bath & Body Works by 58.5% during the first quarter. AIA Group Ltd now owns 2,049 shares of the company's stock worth $98,000 after purchasing an additional 756 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec acquired a new position in shares of Bath & Body Works during the fourth quarter worth $1,431,000. Finally, Steadfast Capital Management LP grew its stake in shares of Bath & Body Works by 7,923.4% during the first quarter. Steadfast Capital Management LP now owns 6,760,507 shares of the company's stock worth $323,152,000 after purchasing an additional 6,676,247 shares in the last quarter. Hedge funds and other institutional investors own 96.19% of the company's stock. About Bath & Body Works (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.See AlsoGet a free copy of the StockNews.com research report on Bath & Body Works (BBWI)Is There a Cure for What is Ailing Teladoc Stock?No One Told These 3 Stocks It’s a Down WeekWhy Medical Products Maker Repligen May Be A Potential Buy At 10%, Is Arbor Realty Trust Dividend Worth It? Investors Should Tune Into RF Industries 

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

ETF portfolio manager, Dave Gilreath offers a perspective on “dividend achievers” and why these deserve a role in your portfolio

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.